Gene:
ADRA2A
adrenergic, alpha-2A-, receptor

Overview

Alternate Names: OTTHUMP00000058849; alpha-2-adrenergic receptor, platelet type; alpha-2A adrenoceptor; alpha-2A-adrenergic receptor; alpha-2AAR subtype C10; alpha2A adrenergic receptor
Alternate Symbols: ADRA2; ADRA2R; ADRAR; ALPHA2AAR; ZNF32
PharmGKB Accession Id: PA35

Details

Cytogenetic Location: chr10 : q25.2
GP mRNA Boundary: chr10 : 112826911 - 112830560
GP Gene Boundary: chr10 : 112816911 - 112833560
Strand: plus
Product Name: OTTHUMP00000058849, alpha-2A-adrenergic receptor, alpha-2AAR subtype C10, alpha2A adrenergic receptor
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Curated Annotations (Curated Annotation)

  1. rs553668 at chr10:112829569 in ADRA2A
    Risk or phenotype-associated allele: A allele. Phenotype: There is increased risk of type 2 diabetes (OR = 1.42, p = 0.04, recessive effect) for carriers of the A allele. Among individuals with low body mass index (<24) or low C-peptide levels (<0.6), there is an increased disease risk in heterozygous subjects (OR = 1.31, p = 0.02, and OR = 1.28, p = 0.03, respectively, using an additive model). These associations were also significant after correcting for rs7903146 genotype in TCF7L2. Study size: 2830 cases and 3740 controls. Study population/ethnicity: Swedish diabetics and unrelated, ethnically-matched non-diabetic controls. Significance metric(s): OR >= 1.28, p <= 0.04. Type of association: CO; GN.
    Related Diseases:
    Diabetes Mellitus, Type 2
    Evidence:
    PMID:19965390
  2. rs553668 at chr10:112829569 in ADRA2A
    Risk or phenotype-associated allele: A allele. Phenotype: Decreased fasting insulin (p = 0.0004) and impaired insulin secretion during intravenous glucose tolerance test in pancreatic islets isolated from subjects (p = 0.03). Study size: 4681. Study population/ethnicity: Replication study of Swedish control subjects. Significance metric(s): p <= 0.03. Type of association: FA; GN.
    Related Diseases:
    Diabetes Mellitus, Type 2
    Evidence:
    PMID:19965390
  3. rs553668 at chr10:112829569 in ADRA2A
    Risk or phenotype-associated allele: A allele. Phenotype: ADRA2A transcript and protein overexpression in pancreatic islets (p < 0.05 for GG versus GA/AA, and for linear regression of expression versus number of risk alleles). Study size: 32. Study population/ethnicity: Human pancreatic islets isolated from Swedes. Significance metric(s): p < 0.05. Type of association: GN; FA.
    Related Diseases:
    Diabetes Mellitus, Type 2
    Evidence:
    PMID:19965390
  4. rs602618 at chr10:112833075 in ADRA2A
    Risk or phenotype-associated allele: A allele. Phenotype: Decreased fasting insulin. Study size: 4681. Study population/ethnicity: Replication study of Swedish control subjects. Significance metric(s): p = 0.001. Type of association: FA; GN.
    Related Diseases:
    Diabetes Mellitus, Type 2
    Evidence:
    PMID:19965390
Variant names are different names that have been used in the literature and other resources to refer to the same variant.

Non-Curated Information

A list of non-curated publications that mention this gene along with other genes is available.

PharmGKB Curated Pathways

Curated Information

The following drugs are in curated knowledge about this gene.

  Drug Class Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
antidepressants
  •   
  •   
  •   
  •   
  • GN
Publications
Phenotype data available No genotype data Literature annotations available Not annotated
Beta Blocking Agents
  •   
  •   
  •   
  • FA
  •   
Publications
  Drug Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
clonidine
  •   
  • PD
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
clozapine
  • CO
  • PD
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
methylphenidate
  • CO
  •   
  •   
  •   
  • GN
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
norepinephrine
  •   
  •   
  •   
  • FA
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
olanzapine
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
sibutramine
  •   
  • PD
  •   
  •   
  •   
Publications
Phenotype data available Genotype Data Available Literature annotations available Not annotated
yohimbine
  •   
  • PD
  •   
  • FA
  •   
Publications

Non-Curated Information

A list of non-curated publications that mention this gene along with other drugs is available.

Curated Information

The following diseases are in curated knowledge about this gene.

  Disease Relationship Evidence
No phenotype data No genotype data Literature annotations available Not annotated
Attention Deficit Disorder with Hyperactivity
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Body Weight Changes
  • CO
  •   
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
diabetes mellitus type 2 and obesity
  • CO
  • PD
  •   
  • FA
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Diabetes Mellitus, Type 2
  • CO
  • PD
  •   
  • FA
  • GN
Publications, Variants
Phenotype data available Genotype Data Available Literature annotations available Not annotated
Hypertension
  •   
  • PD
  •   
  •   
  • GN
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Obesity
  •   
  • PD
  •   
  •   
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Schizophrenia
  • CO
  • PD
  •   
  •   
  •   
Publications
No phenotype data No genotype data Literature annotations available Not annotated
Weight gain
  • CO
  •   
  •   
  •   
  • GN
Publications

Non-Curated Information

A list of non-curated publications that mention this gene along with other diseases is available.

Downloads

You must sign in before you can download data.

LinkOuts

Entrez Gene ID:
150
OMIM Accession:
104210
UCSC Genome Browser ID:
NM_000681
Ref Seq NM Accession:
NM_000681
Ref Seq NP Accession:
AAA51664
AAA51665
AAF91441
AAG00447
AAH35047
AAH50414
AAK01634
AAK26743
AAK51162
AAZ73101
ABB72683
ABY87535
CAH72817
EAW49547
NP_000672
P08913
Ref Seq NT Accession:
AC_000053
AC_000142
NC_000010
NT_030059
NW_001838006
NW_924884
UniProtKB Accesssion:
ADA2A_HUMAN (P08913)
Ensembl ID:
ENSG00000150594
GenAtlas ID:
ADRA2A
GeneCard ID:
ADRA2A
SOURCE ID:
ADRA2A
MutDB ID:
ADRA2A
PromoLign ID:
ortho_4190
HuGE ID:
ADRA2A
Comparative Toxicogenomics Acc ID:
150
ModBase:
P08913
IUPHAR Receptor ID:
α2A-adrenoceptor (25)

Common Searches

Non-Curated Publications

A list of non-curated publications that mention this gene is available.

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (GM61374).
©2001-2010 PharmGKB.